Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Innocan Pharma Corp (CSE: INNO ) 0.2300 UNCHANGED Streaming Delayed Price Updated: 9:30 AM EST, Nov 6, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Innocan Pharma Corp Industry Update: Innocan Pharma Accelerates Commercialization in Europe Following Impressive Revenue Growth May 03, 2023 Via AB Newswire Topics Intellectual Property Exposures Intellectual Property Innovative Delivery Systems Create Unique Opportunities in the Billion-Dollar Pain Market (CSE: INNO) November 14, 2022 Via AB Newswire Topics Cannabis Exposures Cannabis Innocan Pharma Provides an Operational Update September 21, 2022 Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - September 21, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB:... Via Newsfile Topics Intellectual Property Exposures Intellectual Property Innocan Pharma Reports Another Successful Result from a Pre-Clinical Study on a Dog Suffering from Refractory (Drug-Resistant) Epilepsy Following LPT Treatment September 09, 2022 A 4-year-old intact male border collie dog with a body weight of 22 kg was suffering from refractory idiopathic (drug-resistant)... Via Newsfile Innocan Pharma to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022 September 06, 2022 Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - September 6, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... Via Newsfile Innocan Pharma's CBD-Loaded Liposome Platform Technology Demonstrates a Prolonged Release of CBD in Large Animals September 03, 2021 Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - September 3, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... Via Newsfile Topics Intellectual Property Supply Chain Exposures COVID-19 Intellectual Property Supply Chain Innocan Pharma Received Proceeds of CAD $8.2M from the Exercise of Warrants since January 1, 2021 August 27, 2021 Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 27, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... Via Newsfile Topics Supply Chain Exposures COVID-19 Supply Chain Innocan Exercises Option to Enter into a Research and License Agreement with Ramot the Commercial company of the Tel Aviv University August 18, 2021 Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 18, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... Via Newsfile Topics Supply Chain Exposures COVID-19 Supply Chain Innocan Engages Ayurcann Inc. to Manufacture and Distribute Innocan's CBD Topicals in Canada August 11, 2021 Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 11, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF)... Via Newsfile Topics Supply Chain Exposures COVID-19 Supply Chain Innocan Pharma Updates its Progress in the Pre-Clinical Studies of its CBD-Loaded Liposome Platform (LPT) August 03, 2021 Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 3, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... Via Newsfile Topics Intellectual Property Supply Chain Exposures COVID-19 Intellectual Property Supply Chain Innocan Pharma Announces the Filing of a Patent Application for the Treatment and Prevention of Hair Loss July 28, 2021 Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - July 28, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB:... Via Newsfile Topics Intellectual Property Supply Chain Exposures COVID-19 Intellectual Property Supply Chain Former Israeli Minister of Science and Technology and Highly Influential Venture Capitalist to Join Innocan Pharma's Advisory Committee July 14, 2021 Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - July 14, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... Via Newsfile Topics Artificial Intelligence Supply Chain Exposures Artificial Intelligence COVID-19 Supply Chain Innocan Pharma Announces Filing of International Patent Application for Topical Treatment for Diabetic Symptoms July 09, 2021 Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - July 9, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... Via Newsfile Topics Intellectual Property Supply Chain Exposures COVID-19 Intellectual Property Supply Chain Innocan Pharma and Health Investment Group S.A. Sign Exclusive Distribution Agreement for Poland July 01, 2021 Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - July 1, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... Via Newsfile Topics Economy Supply Chain Exposures COVID-19 Economy Supply Chain Innocan Pharma's CBD Integrated Anti-Aging Sleeping Mask Demonstrates a Reduction of the Appearance of Wrinkles by up to 28.8% in 4 Weeks of Clinical Study June 24, 2021 Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 24, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... Via Newsfile Topics Supply Chain Exposures COVID-19 Supply Chain Clinical Study Validates Innocan Pharma's SHIR(R) CBD Eye Serum as an Anti-Puffiness Solution June 16, 2021 Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 16, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... Via Newsfile Topics Supply Chain Exposures COVID-19 Supply Chain Innocan Pharma Announces Patent Application for Novel Cannabis-Based Vaginal Moisturizer and Lubricant Treatment June 14, 2021 Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 14, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... Via Newsfile Topics Intellectual Property Supply Chain Exposures COVID-19 Intellectual Property Supply Chain Innocan Pharma's Liposome Platform Technology Demonstrates a 7-Week Prolonged Release of CBD into Bloodstream in Recent Animal Study June 11, 2021 Herzliya, Israel and Calgary Alberta--(Newsfile Corp. - June 11, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... Via Newsfile Topics Intellectual Property Supply Chain Exposures COVID-19 Intellectual Property Supply Chain Innocan Pharma Among Leading CBD Pharma Companies to Participate at Lytham Partners Summer 2021 Investor Conference June 09, 2021 Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 9, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... Via Newsfile Topics Supply Chain Exposures COVID-19 Supply Chain Innocan Pharma's CBD Loaded Liposome Platform Technology Receives Positive Results from Recent Animal Study May 14, 2021 Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - May 14, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... Via Newsfile Topics Intellectual Property Supply Chain Exposures COVID-19 Intellectual Property Supply Chain Innocan Pharma Engages Lytham Partners to Lead Investor Relations and Shareholder Communication Program May 10, 2021 Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - May 10, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB:... Via Newsfile Topics Cannabis Supply Chain Exposures COVID-19 Cannabis Supply Chain Innocan Pharma Announces Trading on the OTCQB Venture Market and DTC Eligibility of Its Common Shares in the United States May 06, 2021 Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - May 6, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... Via Newsfile Topics Supply Chain Exposures COVID-19 Supply Chain Innocan Pharma and Polyflame Announce an Exclusive Distribution Agreement in France April 22, 2021 Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - April 22, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB:... Via Newsfile Topics Supply Chain Exposures COVID-19 Supply Chain Richard Serbin, Former Johnson & Johnson's VP and a Leading Global Strategy Advisor in the Healthcare Industry, to Join Innocan Pharma's Scientific Advisory Committee April 06, 2021 Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - April 6, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... Via Newsfile Topics Intellectual Property Supply Chain Exposures COVID-19 Intellectual Property Product Safety Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
